DCPG
DCPG ((S)-3,4-DCPG) je lek koji se koristi u naučnim istraživanjima. On deluje kao potentan i selektivan agonist za metabotropni glutamatni receptor mGluR8. On ima antikonvulzivno dejstvo u životinjskim studijama.[1][2] On je takođe istraživan kao mogući tretman za hiperalgeziju.[3]
IUPAC ime | |
---|---|
4-[(1S)-1-amino-2-hidroksi-2-oksoetil]ftalna kiselina | |
Identifikatori | |
CAS broj | 201730-11-2 |
ATC kod | None |
PubChem | CID 16062593 |
IUPHAR/BPS | 1407 |
Hemijski podaci | |
Formula | C10H9NO6 |
Molarna masa | 239,181 g/mol |
|
Reference uredi
- ^ Moldrich RX, Chapman AG, De Sarro G, Meldrum BS European Journal of Pharmacology. 2003 Aug 22;476(1-2):3-16. „Glutamate metabotropic receptors as targets for drug therapy in epilepsy”. PMID 12969743. doi:10.1016/S0014-2999(03)02149-6.
- ^ Folbergrová J, Druga R, Haugvicová R, Mares P, Otáhal J. Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid. Neuropharmacology. 2008 Mar;54(4):665-75. PMID 18191956
- ^ Marabese I, de Novellis V, Palazzo E, Scafuro MA, Vita D, Rossi F, Maione S. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice. Neuropharmacology. 2007 Feb;52(2):253-62. PMID 17113112